Toolkit/phosphorothioate-caged antisense oligonucleotides

phosphorothioate-caged antisense oligonucleotides

RNA Element·Research

Also known as: photocaged antisense oligonucleotides, PS-caged antisense oligonucleotides

Taxonomy: Mechanism Branch / Component. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Phosphorothioate-caged antisense oligonucleotides are mixed-backbone antisense oligonucleotides in which phosphorothioate linkages are modified with 2-nitroveratryl photocages. In the caged state, these modifications suppress target RNA duplex formation and RNase H activity, and UV uncaging restores antisense function to enable light-controlled knockdown of cell-free protein synthesis.

Usefulness & Problems

Why this is useful

This tool provides optical control over antisense oligonucleotide activity, allowing RNA targeting to be switched on with UV light rather than being constitutively active. The reported utility is temporal regulation of knockdown in cell-free protein synthesis systems through light-gated restoration of duplex formation and RNase H-mediated activity.

Problem solved

It addresses the problem of how to keep antisense oligonucleotides inactive until a defined time point while preserving the ability to trigger RNA knockdown on demand. The cited work specifically solves this in the context of cell-free protein synthesis by using photocaged phosphorothioate linkages that block activity until UV exposure.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Component: A low-level RNA part used inside a larger architecture that realizes a mechanism.

Techniques

No technique tags yet.

Target processes

No target processes tagged yet.

Input: Light

Implementation Constraints

antisense based: Truecell free application: Truecofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: spectral hardware requirementlight controlled: Trueswitch architecture: uncaging

Implementation involves mixed-backbone antisense oligonucleotide design with phosphorothioate linkages bearing 2-nitroveratryl photocages. Activation requires UV uncaging, and the demonstrated use case is light-controlled knockdown in a cell-free protein synthesis context; no additional delivery, expression, or construct-format details are provided in the supplied evidence.

The supplied evidence is limited to a single 2023 study and specifically describes application in cell-free protein synthesis. No evidence is provided here for performance in living cells, tissue settings, alternative wavelengths, quantitative dynamic range, or independent replication.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1applicationsupports2023Source 1needs review

Phosphorothioate-caged antisense oligonucleotides enable light-controlled knockdown of cell-free protein synthesis.

Accessible light-controlled knockdown of cell-free protein synthesis using phosphorothioate-caged antisense oligonucleotides
Claim 2applicationsupports2023Source 1needs review

Phosphorothioate-caged antisense oligonucleotides enable light-controlled knockdown of cell-free protein synthesis.

Accessible light-controlled knockdown of cell-free protein synthesis using phosphorothioate-caged antisense oligonucleotides
Claim 3applicationsupports2023Source 1needs review

Phosphorothioate-caged antisense oligonucleotides enable light-controlled knockdown of cell-free protein synthesis.

Accessible light-controlled knockdown of cell-free protein synthesis using phosphorothioate-caged antisense oligonucleotides
Claim 4applicationsupports2023Source 1needs review

Phosphorothioate-caged antisense oligonucleotides enable light-controlled knockdown of cell-free protein synthesis.

Accessible light-controlled knockdown of cell-free protein synthesis using phosphorothioate-caged antisense oligonucleotides
Claim 5applicationsupports2023Source 1needs review

Phosphorothioate-caged antisense oligonucleotides enable light-controlled knockdown of cell-free protein synthesis.

Accessible light-controlled knockdown of cell-free protein synthesis using phosphorothioate-caged antisense oligonucleotides
Claim 6mechanismsupports2023Source 1needs review

Installation of 2-nitroveratryl photocages onto phosphorothioate linkages in mixed-backbone antisense oligonucleotides suppresses duplex formation and RNase H activity until UV uncaging.

The PubMed/PMC record states the paper introduces a mild one-step chemoselective installation of 2-nitroveratryl photocages onto phosphorothioate linkages in mixed-backbone antisense oligonucleotides, suppressing duplex formation and RNase H activity until UV uncaging, and applies this to light-controlled knockdown in cell-free protein synthesis.
Claim 7mechanismsupports2023Source 1needs review

Installation of 2-nitroveratryl photocages onto phosphorothioate linkages in mixed-backbone antisense oligonucleotides suppresses duplex formation and RNase H activity until UV uncaging.

The PubMed/PMC record states the paper introduces a mild one-step chemoselective installation of 2-nitroveratryl photocages onto phosphorothioate linkages in mixed-backbone antisense oligonucleotides, suppressing duplex formation and RNase H activity until UV uncaging, and applies this to light-controlled knockdown in cell-free protein synthesis.
Claim 8mechanismsupports2023Source 1needs review

Installation of 2-nitroveratryl photocages onto phosphorothioate linkages in mixed-backbone antisense oligonucleotides suppresses duplex formation and RNase H activity until UV uncaging.

The PubMed/PMC record states the paper introduces a mild one-step chemoselective installation of 2-nitroveratryl photocages onto phosphorothioate linkages in mixed-backbone antisense oligonucleotides, suppressing duplex formation and RNase H activity until UV uncaging, and applies this to light-controlled knockdown in cell-free protein synthesis.
Claim 9mechanismsupports2023Source 1needs review

Installation of 2-nitroveratryl photocages onto phosphorothioate linkages in mixed-backbone antisense oligonucleotides suppresses duplex formation and RNase H activity until UV uncaging.

The PubMed/PMC record states the paper introduces a mild one-step chemoselective installation of 2-nitroveratryl photocages onto phosphorothioate linkages in mixed-backbone antisense oligonucleotides, suppressing duplex formation and RNase H activity until UV uncaging, and applies this to light-controlled knockdown in cell-free protein synthesis.
Claim 10mechanismsupports2023Source 1needs review

Installation of 2-nitroveratryl photocages onto phosphorothioate linkages in mixed-backbone antisense oligonucleotides suppresses duplex formation and RNase H activity until UV uncaging.

The PubMed/PMC record states the paper introduces a mild one-step chemoselective installation of 2-nitroveratryl photocages onto phosphorothioate linkages in mixed-backbone antisense oligonucleotides, suppressing duplex formation and RNase H activity until UV uncaging, and applies this to light-controlled knockdown in cell-free protein synthesis.

Approval Evidence

1 source2 linked approval claimsfirst-pass slug phosphorothioate-caged-antisense-oligonucleotides
Accessible light-controlled knockdown of cell-free protein synthesis using phosphorothioate-caged antisense oligonucleotides

Source:

applicationsupports

Phosphorothioate-caged antisense oligonucleotides enable light-controlled knockdown of cell-free protein synthesis.

Accessible light-controlled knockdown of cell-free protein synthesis using phosphorothioate-caged antisense oligonucleotides

Source:

mechanismsupports

Installation of 2-nitroveratryl photocages onto phosphorothioate linkages in mixed-backbone antisense oligonucleotides suppresses duplex formation and RNase H activity until UV uncaging.

The PubMed/PMC record states the paper introduces a mild one-step chemoselective installation of 2-nitroveratryl photocages onto phosphorothioate linkages in mixed-backbone antisense oligonucleotides, suppressing duplex formation and RNase H activity until UV uncaging, and applies this to light-controlled knockdown in cell-free protein synthesis.

Source:

Comparisons

Source-backed strengths

The key demonstrated strength is reversible optical gating of antisense function through a defined chemical modification: 2-nitroveratryl photocages on phosphorothioate linkages. The source reports suppression of both RNA duplex formation and RNase H activity in the dark state, followed by UV-enabled restoration sufficient for light-controlled knockdown of cell-free protein synthesis.

Ranked Citations

  1. 1.
    StructuralSource 1Communications Chemistry2023Claim 1Claim 2Claim 3

    Extracted from this source document.